Valeant Pharmaceuticals (VRX +0.4%) completes its executive management team by naming Laizer...


Valeant Pharmaceuticals (VRX +0.4%) completes its executive management team by naming Laizer Kornwasser as EVP/Group Chairman with responsibility for the firm's Canadian operations, U.S. Neurology, and various other U.S. functions, including managed care and distribution. Kornwasser was a senior exec at Medco Health prior to its acquisition by Express Scripts. (Recent other Valeant appointments) (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs